Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer
Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer
Recruiting · NCT05640609 · Registry updated 2023-05-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 1 / Phase 2 | 2023-05-16 | NCT05640609 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| West China Hospital | 359 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Liu Ming | Chengdu | China | 1 |